Figure 8.The schematic diagram demonstrating the association of elevated levels of co-chaperone CHIP with better therapeutic benefits of rADSCs. Co-chaperone CHIP overexpression on rADSCs regulates the IGF1 secretion. Furthermore, transplantation of engineered rADSCs in aging-SHR model augments the cardioprotective effects and suppresses cardiac remodeling.
